FY2026 · ended Apr 24, 2026 · Revenue $3.10B · Filed Jun 29, 2026
MiniMed Group, Inc. (MMED) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Apr 24, 2026, it reported revenue of $3.1 billion and a net loss of $333.0 million. Free cash flow was -$420.0 million. As of Jul 31, 2026 it held $207.0 million in cash and investments and $59.0 million in total debt.
Revenue
$3.10B
Net income
$-333.00M
Operating cash flow
$-197.00M
Free cash flow
$-420.00M
EPS
$-1.30
Dividend per share
None
Shares outstanding
280.84M
Net cash
$148.00M
as of Jul 31, 2026
Operating margin
-6.1%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMED (Nasdaq), MMEDV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northridge, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 2062583
- Former names
- MDT Sub Holdings, Inc. (until May 30, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Apr 24, 2026 |
|---|---|
| Revenue | $3.1B |
| Operating income | -$190.0M |
| Net income | -$333.0M |
| Diluted EPS | -$1.30 |
| Operating cash flow | -$197.0M |
| Free cash flow | -$420.0M |
| Total assets | $4.6B |
| Total liabilities | $1.0B |
| Stockholders' equity | $3.6B |
| Cash and investments | $298.0M |
| Total debt | $53.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change in control, Officer or director change, Regulation FD disclosure
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2026 | Oct 9, 2026 |
| 10-Q | Quarterly report | Sep 8, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 1, 2026 | Sep 1, 2026 |
| ARS | Annual report to shareholders | Aug 21, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2026 | Jul 30, 2026 |
All 108 MiniMed Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.